SG Americas Securities
EPZM

SG Americas Securities’s Epizyme, Inc EPZM Stock Holding History

SG Americas Securities’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,791
Closed -$14K – 3686
2022
Q1 		$14K Sell
11,791
-5,301
-31% -$8.64K ﹤0.01% 2896
2021
Q4 		$43K Sell
17,092
-23,194
-58% -$91.1K ﹤0.01% 3211
2021
Q3 		$206K Buy
+40,286
New +$245K ﹤0.01% 3221
2021
Q2 		– Sell
-18,567
Closed -$162K – 3377
2021
Q1 		$162K Buy
18,567
+2,675
+17% +$27.7K ﹤0.01% 2813
2020
Q4 		$173K Sell
15,892
-39,003
-71% -$481K ﹤0.01% 2712
2020
Q3 		$655K Buy
54,895
+43,639
+388% +$585K ﹤0.01% 1458
2020
Q2 		$181K Sell
11,256
-4,093
-27% -$71.4K ﹤0.01% 2943
2020
Q1 		$238K Buy
15,349
+4,929
+47% +$106K ﹤0.01% 2389
2019
Q4 		$256K Buy
+10,420
New +$155K ﹤0.01% 2308
2019
Q2 		– Sell
-14,500
Closed -$180K – 3552
2019
Q1 		$180K Buy
+14,500
New +$162K ﹤0.01% 2643
2017
Q4 		– Sell
-10,966
Closed -$209K – 3769
2017
Q3 		$209K Sell
10,966
-2,398
-18% -$36.6K ﹤0.01% 2549
2017
Q2 		$202K Buy
13,364
+6,072
+83% +$91.8K ﹤0.01% 2422
2017
Q1 		$125K Sell
7,292
-13,188
-64% -$176K ﹤0.01% 2823
2016
Q4 		$248K Buy
+20,480
New +$214K ﹤0.01% 2195
2015
Q2 		– Sell
-7,696
Closed -$145K – 2909
2015
Q1 		$145K Buy
+7,696
New +$159K ﹤0.01% 2065
2014
Q2 		– Sell
-13,924
Closed -$317K – 2762
2014
Q1 		$317K Buy
+13,924
New +$422K ﹤0.01% 1712

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SG Americas Securities's EPZM Position: Q2 2022 in Review

SG Americas Securities sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 11,791 shares — an estimated $14K sold.

SG Americas Securities first reported a position in EPZM in Q1 2014 and held it in 16 quarters. The position peaked at $655K in Q3 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • SG Americas Securities reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • SG Americas Securities sold 11,791 Epizyme, Inc shares in Q2 2022, an estimated $14K.
  • SG Americas Securities first reported a position in Epizyme, Inc in Q1 2014 and held it in 16 quarters.
  • SG Americas Securities's Epizyme, Inc position peaked at $655K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on SG Americas Securities's 13F filing for Q2 2022, filed 29 Jul 2022.